Establishes certain prescription drug data reporting requirements for hospitals.
Introduced First Reading Assembly Referred to AHN
Email me when A 3265 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track A 3265. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill adds hospitals to New Jersey's prescription‑drug reporting system, obligating them to submit price, volume, rebate and net‑income information for specified drugs. It imposes per‑jury certification, civil penalties and audit authority, and directs the Division to publish annual pricing trend reports. A new Drug Affordability Council is created to review the data and advise on policy.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about A 3265
3 free questions a day, no accountHearings
- Health Infrastructure — MeetingHealth Infrastructure · Oct 15, 2026
History
- Introduced, Referred to Assembly Health Infrastructure Committee
Sponsors
- Hutchison, Dan · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when A 3265 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 3265 freeOr ask your AI assistant about A 3265 directly:
Add to Claude, ChatGPT or Cursor